ELDER PHARMA PLANS UNIT, BRAND BUYOUTS

Elder Pharmaceuticals is planning to acquire a formulation facility in India as well as foreign and local brands. This is a part of the company's expansion plan in dermatology, diabetes and cardiology. Jagdish Saxena, managing director, said the company was looking at capacity expansion for formulations, considering the future for organic and inorganic growth. "We are in talks with local and international companies for a facility acquisition and also for picking up brands to expand our portfolio. The buyout deals are likely to be finalised in another three to four months," he said.

BigNews Network (http://feeds.bignewsnetwork.com/redir.php?jid=ff4ce86dd852131a&cat=6dcd932030878143)